ADR Biomedical Holdings
3750.TInformation & Communication
Filed as FRACTALE Corporation (2022-06–2022-06), Cytori Cell Research Institute,Inc. (2022-08–2025-11), ADR120S, Inc. (2025-11–2026-06)
Major holders (5%+) · 6
| Holder | Stake |
|---|---|
| Hashimoto Masamichi | 18.50% |
| HG CAPITAL CO., LTD. | 13.14% |
| FTL Capital Management K.K | 11.05% |
| Catalyst Investment Group Co., Ltd. | 10.67% |
| TOKYO WELD CO., LTD. | 9.22% |
| Toshiyasu Horie | 5.16% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 7
| YOSHIRO KUBOTA | 4.21% |
| Naturali Co., Ltd. | 3.94% |
| Norio Shirahama | 3.27% |
| ACA Inc, | 2.58% |
| KEISUKE KUBOTA | 1.15% |
| UESHIMA Co., Ltd. | 0.46% |
| Kankuro Ueshima | 0.00% |
Ownership history · 27
| Holder | Ratio | Change |
|---|---|---|
| KEISUKE KUBOTA2026-05-08 | 1.15% | new |
| YOSHIRO KUBOTA2026-05-08 | 4.21% | new |
| TOKYO WELD CO., LTD.2026-05-08 | 9.22% | new |
| FTL Capital Management K.K2025-10-22 | 11.05% | new |
| Kankuro Ueshima2025-07-15 | 0.00% | -5.05pp |
| UESHIMA Co., Ltd.2025-07-15 | 0.46% | no change |
| UESHIMA Co., Ltd.2025-07-15 | 0.46% | no change |
| Naturali Co., Ltd.2025-07-15 | 3.94% | new |
| UESHIMA Co., Ltd.2025-04-09 | 0.46% | no change |
| UESHIMA Co., Ltd.2025-04-09 | 0.46% | new |
| Kankuro Ueshima2025-04-09 | 5.05% | new |
| Hashimoto Masamichi2025-03-06 | 18.50% | new |
| Toshiyasu Horie2025-03-05 | 5.16% | -1.98pp |
| Norio Shirahama2024-05-31 | 3.27% | -0.59pp |
| Toshiyasu Horie2024-05-31 | 7.14% | -1.89pp |
| Catalyst Investment Group Co., Ltd.2024-03-28 · amended | 10.67% | +5.07pp |
| Catalyst Investment Group Co., Ltd.2024-03-28 · amended | 5.60% | -3.28pp |
| Catalyst Investment Group Co., Ltd.2024-03-28 · amended | 8.88% | new |
| HG CAPITAL CO., LTD.2024-03-27 · amended | 13.14% | -2.83pp |
| ACA Inc,2024-03-22 · amended | 2.58% | -2.76pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.